Results 221 to 230 of about 480,913 (287)

Levofloxacin-associated Torsades De Pointes.

, 2010
Yumiko Takano, Akihiro Terasawa, Yûzo Hayashi, So Oshitani, Shinji Ishikawa, Yousuke Inoue, Takanori Shumiya, Keita Kondo   +7 more
openalex   +2 more sources

Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.

Europace, 2012
A. Dunnink, J. V. van Opstal, P. Oosterhoff, S. Winckels, J. Beekman, R. van der Nagel, S. Cora Verduyn, M. Vos   +7 more
semanticscholar   +1 more source

Human Atrial Natriuretic Peptide Suppresses Torsades de Pointes in Rabbits

, 2008
Hideko Inaba, Noriyuki Hayami, Kohsuke Ajiki, Yasuyuki Sugishita, Tomoyuki Kunishima, Noboru Yamagishi, Satoshi Yamagishi, Yuji Murakawa   +7 more
openalex   +2 more sources

Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).

British Journal of Clinical Pharmacology, 2012
J. Ritter
semanticscholar   +1 more source

Torsade de pointes during low-dosage sotalol therapy in haemodialysis patients [PDF]

, 2017
Bühler, H., Huynh-Do, U., Keusch, G., Sulzer, M., Wahl, C.   +4 more
core  

Comorbidities and use of proarrhythmic drugs in patients with torsade de pointes arrhythmia [PDF]

Krzysztof Nowiński, Johan Fastbom, Bengt Danielsson, Erland Jonsson, M L Dahl, Mats Andersson   +5 more
openalex   +1 more source

Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model

, 2008
András Farkas, John Dempster, Susan J. Coker   +2 more
openalex   +1 more source

Drug-Induced Torsade de Pointes. From Molecular Biology to Bedside.

, 2000
Juan Tamargo
openalex   +1 more source

QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.

Deutsches Ärzteblatt International, 2011
K. Wenzel‐Seifert, M. Wittmann, E. Haen   +2 more
semanticscholar   +1 more source